Drugs / CS8080
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00796575 | Nov → Dec 2008 | — | Daiichi Sankyo | Terminated | No outcome recorded |
| Phase 1 | NCT00613431 | Jan → Aug 2008 | — | Daiichi Sankyo | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CS-8080 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00796575 ↗ |
| Action | Activate | “LXR-alpha agonist” CHEMBL3545238 ↗1“LXR-beta agonist” CHEMBL3545238 ↗ |
| Target | NR1H2 | “LXR-beta agonist” CHEMBL3545238 ↗ |
| Target | NR1H3 | “LXR-alpha agonist” CHEMBL3545238 ↗ |